Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-606-8 | CAS number: 123-17-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to test guidelines and in accordance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- other: EC 0 J. No. L 136 (2000)
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,6,8-trimethylnonan-4-ol
- EC Number:
- 204-606-8
- EC Name:
- 2,6,8-trimethylnonan-4-ol
- Cas Number:
- 123-17-1
- Molecular formula:
- C12H26O
- IUPAC Name:
- 2,6,8-trimethylnonan-4-ol
- Details on test material:
- - Name of test material (as cited in study report): 2,6,8-trimethyl-4-nonanol
- Molecular weight (if other than submission substance): 186.3
- Physical state: Liquid
- Analytical purity: The purity of the test material sample was determined to be 96.05% trimethylnonanol, with five minor components present at 0.1% or greater by gas chromatography. Identity was confirmed by infrared (IR) spectroscopy and gas chromatography-mass spectrometry (GC/MS).
Constituent 1
Method
- Target gene:
- histidine (his+) or tryptophan (trp+)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- The S-9 activation system consists of an NADPH regeneration system plus the S-9 fraction of rat liver homogenate. The S-9 fraction of rat liver homogenates was prepared from Aroclor 1254 induced male Sprague-Dawley rats.
- Test concentrations with justification for top dose:
- The concentrations selected under these conditions were 5000, 3333, 1000,333, 100,33, 10,3.3, and 1 ug/plate in the presence and absence of S-9.
- Vehicle / solvent:
- 2,6,8-trimethyl-4-nonano(TMN) was dissolved in DMSO. The selected concentrations of the test material in the treatment medium or in the stock solutions used for the treatment in the main assay were verified by gas chromatography with flame ionization detection (GC/FID).
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: See Table below
- Details on test system and experimental conditions:
- Preliminary Assay
Selection of dose levels for the main mutagenicity assay was based upon the toxicity and precipitation profile of the test article assessed in a preliminary assay. The tester strains were exposed to the test article via the pre-incubation modification of the Ames test described by Maron and Ames (1 983). In the preincubation methodology the tester strain and the test article are pre-incubated at 37C for approximately 20 minutes prior to the addition of molten agar. The test material was evaluated up to a concentration of 5000 ug/plate. The concentrations selected under these conditions were 5000, 3333, 1000,333, 100,33, 10,3.3, and 1 ug/plate in the presence and absence of S-9.
For the assay with activation, the bacteria (0.1 ml), test article (0.05 ml of the appropriately diluted test material or solvent), and the S-9 mix (0.5 ml) were placed into sterile tubes incubated at 37OC for approximately 20 minutes and 2 ml of top agar (supplemented with trace amounts of histidine and biotin or tryptophan) was added, mixed and poured onto minimal glucose agar plates. With some solvents such as dimethyl sulfoxide and water, the volume of the test materiaVsolverf may have been increased up to 0.1 ml in order to achieve the desired concentrations for the testing of insoluble materials. For the non-activation assay, S-9 mix was omitted and replaced by 0.5 ml of 0.2M phosphate buffer, pH 7.4. The plates were then incubated for approximately 52 f 4 hour in an incubator at 37C. This preliminary assay was conducted by exposing all strains to negative controls (three plates) and positive controls (three plates) and nine concentrations of test article (three platesldose), in both the presence and absence of S-9 activation. The highest concentration evaluated represented the limit concentration for this assay.
Mutagenicity Assay
In selecting concentration levels for the mutagenicity assay, the following guidelines were employed. Concentrations were selected based on the preliminary assay such that precipitate did not interfere with the counting of colonies. Whenever possible, the highest concentration for the mutagenicity assay was selected to give some indication of toxicity without exceeding 5 mg/plate. For freely soluble, nontoxic test articles, the highest concentration level was 5 mg/plate. For precipitating, nontoxic test articles, the highest concentration level was selected in an attempt to yield precipitate at only the top one or two concentration levels.
The test article was tested at a minimum of 7 concentration levels along with appropriate negative and positive controls with all tester strains (TA98, TA100, TA1535, TA1537, and WP2uvrA), with and without S-9 activation. All concentration levels of the test article, negative controls, and positive controls were plated in triplicate. A confirmatory assay was performed in the event of equivocal or positive findings in the mutagenicity assay. - Evaluation criteria:
- Plate Counts/Evaluation
Prior to scoring the assay plates, all tester strain cultures were checked for the appropriate genetic markers. The condition of the bacterial background lawn was evaluated for evidence of cytotoxicity and test article precipitate. Evidence of cytotoxicity was scored relative to the vehicle control and recorded along with the revertant counts for that concentration. Revertant colonies were counted either by automated colony counter or
manually (generally when fewer than 100 colonies). Plates tht were not evaluated immediately following the incubation period were held at 5 +/- 3OC, until the colony counting and bacterial background lawn evaluation could take place but not more than two weeks.
Criteria For Determination of a Valid Test
The following criteria must have been met for the mutagenicity assay to be considered valid.
Tester Strain Integrity
To demonstrate the presence of the rfa mutation, all S. typhimurium tester strain cultures must have exhibited sensitivity to crystal violet. To demonstrate the presence of the pKM101 plasmid R-factor, tester strain cultures of TA98 and TA100 must have exhibited resistance to ampicillin as described above.
Negative Control Values
Based on in house and literature derived historical control data, all tester strain cultures should have exhibited characteristic numbers of revertants per plate in the negative controls (vehicle). The mean revertants per plate should have been within the following ranges (inclusive): TA98, 10-50; TA100, 80-200; TA1535,5-45; TA1537, 3-21; WP2uvrA, 10-54. Untreated controls, when part of the design, must have also been within the ranges cited above.
Positive Control Values
Each mean positive control value must have exhibited at least a 3.0- fold increase over the respective mean negative control value (vehicle) for each tester strain.
Toxicity (see below) - Statistics:
- Means and Standard Deviations were calculated.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In the presence of S-9, TA98 and TA1537 exhibited cytotoxicity at >/-1000 ug/plate and TA100 from >/-100 ug/plate. In the absence of S-9 TA100 and TA1537 exhibited cytotoxicity from 10 ug/plate and TA98 from 33 ug/plate. Others tested up to limit conc.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- The mutagenicity of 2,6,8-trimethyl-4-nonano(lt rimethylnonanol) was evaluated using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and E. coli WP2uvrA in the presence and absence of a metabolic activation system (S-9). Based on its limited solubility in water, DMSO was selected as the vehicle due to its solubility in this solvent and its compatibility with the test system.
Preliminary Assay
A preliminary assay was conducted on all tester strains (3 plates per treatment) in both the presence and absence of metabolic activation (S-9 mix) at concentrations ranging from 1-5000 ug/plate. In the absence of S-9, TA98 exhibited cytotoxicity from 100 ug/plate while TA100 and TA1537 exhibited cytoxicity from 10 and 33 ug/plate, respectively. In the presence of S-9 TA98 and TA1537 exhibited cytotoxicity at 333 ug/plate and above, while TA100 exhibited cytotoxicity from 100 ug/plate. TA1535 and WP2uvrA exhibited no cytotoxicity in either the absence or presence of metabolic activation. Mean revertants for the negative and positive controls for all strains exhibited numbers that satisfied the criteria for a valid assay. No significant increases in mutant counts were observed that satisfied the criteria (TA98, TA1535, TA1537, and WP2uvrA: 3-fold and TA100: 2-fold), for a positive assay response. No precipitation was observed on any of the plates at any concentration in either the presence or absence of S-9.
Mutagenicity Assay
The mutagenicity assay was conducted up to a maximal level of 5000 ug/plate in all tester strains in the presence of metabolic activation and for TA98, TA1535, and E.coli WP2uvrA in the absence of S-9. TA100, and TA1537 were evaluated from 0.1-333 ug/plate in the absence of S-9. In the presence of S-9, TA98 and TA1537 exhibited cytotoxicity at 1000 and 5000 ug/plate and TA100 from 100-5000 ug/plate. In the absence of S-9 TA100 and TA1537 exhibited cytotoxicity from 10 ug/plate and TA98 from 33 ug/plate. The other tester strains (TA1535 and WP2uvrA) did not exhibit toxicity in terms of decreased background lawn up to the maximal concentration evauluated (5000 ug/plate) in either the presence or absence of metabolic activation. No precipitation was observed on any of the plates at any concentration in either the presence or absence of S-9. Theconcentrations of test material in the dosing solutions were analytically confirmed to be between 92- 1 15% of the stated values. The positive and negative control revertant counts satisfied the criteria for a valid assay. Again, no significant increases in mutant counts were observed that satisfied the criteria for a positive assay response. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table. Mutagenicity Assay Results (Assay B1)
Mean + SD | |||||
ug/Plate | TA98 | TA100 | TA1535 | TA1537 | WP2uvrA |
With S-9 | |||||
0.0 | 32 + 8.1 | 136 + 19.1 | 15 + 4.7 | 11 + 4.0 | 41 + 12.0 |
1.0 | 33 + 3.0 | 143 + 17.2 | 18 + 4.0 | 10 + 3.5 | 47 + 7.0 |
3.3 | 26 + 9.5 | 158 + 13.7 | 18 + 5.1 | 11 + 3.5 | 46 + 5.1 |
10 | 32 + 5.5 | 139 + 18.6 | 15 + 2.3 | 9 + 2.1 | 47 + 9.0 |
33 | 30 + 4.4 | 153 + 6.8 | 14 + 1.5 | 11 + 4.0 | 45 + 13.0 |
100 | 30 + 1.0 | 69 + 16.81 | 14 + 2.6 | 9 + 2.1 | 47 + 6.5 |
1000 | 31 + 8.01 | 29 + 11.42 | 14 + 2.6 | 0 + 0.03 | 36 + 11.2 |
5000 | 21 + 4.61 | 13 + 4.02 | 12 + 4.7 | 0 + 0.03 | 43 + 1.5 |
PCb | 287 + 25.4 | 1310 + 34.4 | 120 + 10.1 | 127 + 8.1 | 421 + 26.1 |
Without S-9 | |||||
0.0 | 25 + 4.9 | 123 + 28.9 | 19 + 4.2 | 8 + 2.1 | 39 + 4.6 |
0.100 | --- | 124 + 6.5 | --- | 9 + 6.4 | --- |
0.333 | --- | 129 + 17.8 | --- | 11 + 2.9 | --- |
1.0 | 23 + 4.4 | 128 + 14.6 | 21 + 2.1 | 7 + 2.6 | 38 + 2.5 |
3.3 | 25 + 7.5 | 122 + 4.4 | 18 + 2.1 | 12 + 2.1 | 35 + 7.8 |
10 | 22 + 3.6 | 67 + 9.51 | 18 + 2.5 | 4 + 1.51 | 41 + 1.0 |
33 | 23 + 2.01 | 58 + 25.01/2 | 13 + 2.5 | 3 + 3.11/3 | 36 + 4.0 |
100 | 24 + 3.81 | 40 + 52.91/2/3 | 16 + 5.8 | 2 + 0.6 1/3 | 44 + 4.9 |
333 | --- | 0 + 0.03 | --- | 0 + 0.03 | --- |
1000 | 17 + 7.51 | --- | 15 + 6.4 | --- | 36 + 7.6 |
5000 | 19 + 2.61 | --- | 10 + 2.6 | --- | 40 + 2.6 |
PCc | 660 + 52.5 | 1453 + 28.9 | 1465 + 29.1 | 845 + 45.8 | 384 + 40.5 |
1 = Slightly reduced, 2= Moderately reduced, 3 = Severely reduced or absent
b TA98: Benzo(a)pyrene. 2.5 ug/plate
TA100: 2-Aminoanthracene. 2.5 ug/plate
TA1535: 2-Aminoanthracene, 2.5 ug/plate
TA1537: 2-Aminoanthracene, 2.5 ug/plate
WP2uvrA: 2-Aminoanthracene, 25.0 ug/plate
cTA98: 2-Nitrofluorene. 5.0 ug/plate
TA100: Sodium azide, 10.0 ug/plate
TA1535: Sodium azide. 10.0 ug/plate
TA1537: ICR-191, 2.0 ug/plate
WP2uvrA: 4-Nitroquinoline-N-oxide, 0.4 ug/plate
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Based on the results of the study, trimethylnonanol was concluded to be negative in the bacterial reverse mutation assay under the conditions used in the study. - Executive summary:
The mutagenicity of 2,6,8-trimethyl-4- nonanol (trimethylnonanol) was evaluated using Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and E.coli WP2uvrA in the presence and absence of a metabolic activation system (S-9). Dimethylsulfoxide (DMSO) was selected as the solvent of choice due to the solubility of the test material in this solvent and its compatibility with the test system. A preliminary assay was conducted on all tester strains in both the presence and absence of metabolic activation at nine concentrations ranging from 1-5000 μg/plate. In the absence of S-9, TA98 exhibited cytotoxicity from 100 μg/plate and TAl00 and TA1537 from 33 μg/plate. In the presence of S-9, TA98 and TA1537 exhibited cytotoxicity at 333 μg/plate and above and TAl00 from 100 μg/plate. TA1535 and WP2uvrA exhibited no cytotoxicity in either the absence or presence of metabolic activation. Mean revertants for the negative and positive controls for all strains exhibited numbers that satisfied the criteria for a valid assay. No significant increases in mutant counts were observed that satisfied the criteria (TA98, TA1535, TA1537, and WP2uvrA: 3-fold and TA100: 2-fold), for a positive assay response. No precipitation was observed on any of the plates at any concentration in either the presence or absence of S-9.
The mutagenicity assay was conducted at 7-8 concentrations up to a maximal level of 5000 μg/plate in all tester strains in the presence and absence of metabolic activation. In the presence of S-9, TA98 and TA1537 exhibited cytotoxicity at 1000 and 5000 μg/plate and TA100 from 100-5000 μg/plate. In the absence of S-9, TA100 and TA1537 exhibited cytotoxicity from 10 μg/plate and TA98 from 33 μg/plate. The other tester strains (TA1535 and WP2uvrA) did not exhibit toxicity in terms of decreased background lawn up to the maximal concentration evaluated (5000 μg/plate) in either the presence or absence of metabolic activation. The concentrations of test
material in the dosing solutions were analytically confirmed to be between 92- 115% of the stated values. The positive and negative control revertant counts satisfied the criteria for a valid assay. Again, no significant increases in mutant counts were observed that satisfied the criteria for a positive assay response. Hence, trimethylnonanol is concluded to be negative in the bacterial reverse mutation assay under the conditions used in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.